Automation and validation of DNA-banking systems
Authors:
- Melissa ThorntonMTMelissa Thornton
- Amanda GladwinAGAmanda Gladwin
- Robin PayneRPRobin Payne
- Rachael MooreRMRachael Moore
- Carl CresswellCCCarl Cresswell
- Douglas McKechnieDMDouglas McKechnie
- Steve KellySKSteve Kelly
- Ruth MarchRMRuth March
- 1 October 2005
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 10 (20) , 1369-1375
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Novel Technology and the Development of Pharmacogenetics within the Pharmaceutical IndustryPharmacogenomics, 2005
- Collaborative Design for Automated DNA Storage That Allows for Rapid, Accurate, Large-Scale StudiesASSAY and Drug Development Technologies, 2004
- Translation of pharmacogenomics and pharmacogenetics: a regulatory perspectiveNature Reviews Drug Discovery, 2004
- Pharmacogenomic Data Submissions to the FDA: Clinical Case StudiesPharmacogenomics, 2004
- An empirical survey on biobanking of human genetic material and data in six EU countriesEuropean Journal of Human Genetics, 2003
- DNA Banking for Epidemiologic Studies: A Review of Current PracticesEpidemiology, 2002
- High‐throughput SNP genotypingComparative and Functional Genomics, 2002
- Pharmacogenetics – legal, ethical and regulatory considerationsPharmacogenomics, 2001
- Clinical application of pharmacogeneticsTrends in Molecular Medicine, 2001
- A new human genetic resource: a DNA bank established as part of the Avon Longitudinal Study of Pregnancy and Childhood (ALSPAC)European Journal of Human Genetics, 2000